Torbjörn Mattias Koivisto
Director/Board Member bei XSPRAY PHARMA AB
Vermögen: 23 624 $ am 31.03.2024
Profil
Torbjörn Mattias Koivisto is currently a Director at Xspray Pharma AB, Iaru AB, Cinclus Pharma Holding AB, and a Partner at Kol Arts & Craft Handelsbolag.
He is also a Deputy Director at Rjc Roger Johansson Consulting AB and Virdings Alle Invest AB.
In the past, he served as an Independent Director at Moberg Pharma AB, and held Director positions at Kibion AB, Forslid & Co. AB, and ApotekSamariten AB.
He was also a Principal at Bird & Bird LLP, Mannheimer Swartling Advokatbyrå AB, and Lindahl & Rothoff.
He holds a graduate degree from the University of Uppsala.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XSPRAY PHARMA AB
0,02% | 31.12.2022 | 6 000 ( 0,02% ) | 23 624 $ | 31.03.2024 |
Aktive Positionen von Torbjörn Mattias Koivisto
| Unternehmen | Position | Beginn |
|---|---|---|
| XSPRAY PHARMA AB | Director/Board Member | 01.01.2017 |
| Iaru AB | Director/Board Member | 01.01.2006 |
| Kibacq AB | Director/Board Member | - |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Director/Board Member | 01.04.2018 |
| Kol Arts & Craft Handelsbolag | Corporate Officer/Principal | - |
| Rjc Roger Johansson Consulting AB | Corporate Officer/Principal | - |
| Virdings Alle Invest AB | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Torbjörn Mattias Koivisto
| Unternehmen | Position | Ende |
|---|---|---|
| MOBERG PHARMA AB | Director/Board Member | 15.05.2018 |
| BIO VITOS PHARMA AB | Director/Board Member | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ausbildung von Torbjörn Mattias Koivisto
| University of Uppsala | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MOBERG PHARMA AB | Health Technology |
| XSPRAY PHARMA AB | Health Technology |
| BIO VITOS PHARMA AB | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Bird & Bird LLP
 Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Bird & Bird LLP provide legal services. The firm focuses on aviation and aerospace, banking and financial services, communications, eCommerce, information technology, life sciences, media, and sports sectors. The company was founded in 1846 and is headquartered in London, the United Kingdom. | Commercial Services |
Mannheimer Swartling Advokatbyrå AB
 Mannheimer Swartling Advokatbyrå AB Miscellaneous Commercial ServicesCommercial Services Mannheimer Swartling Advokatbyrå AB provides legal advisory services. It specializes in corporate and business law serving various sectors such as energy, real estate, financial, automobile, health care, construction, information technology, telecommunications, media, and transportation. The company was founded on July 1, 1990 and is headquartered in Stockholm, Sweden. | Commercial Services |
Lindahl & Rothoff
 Lindahl & Rothoff Information Technology ServicesTechnology Services Lindahl & Rothoff is an IT services company based in Lund, Sweden. Lindahl & Rothoff was acquired by Martinsson Gruppen AB, part of Atea ASA from March 09, 2005 on September 06, 2004. | Technology Services |
Kibion AB
 Kibion AB Medical SpecialtiesHealth Technology Kibion AB manufactures and distributes medical test and analytical instruments. It provides solutions for rapid urea breath tests for diagnosing the stomach ulcer bacterium Helicobacter pylori. The firm offers products such as Heliprobe System, Diabact Urea Breath Test, and Kibion Dynamic. The company was founded in 2005 and is headquartered in Uppsala, Sweden. | Health Technology |
| Iaru AB | |
ApotekSamariten AB
 ApotekSamariten AB Drugstore ChainsRetail Trade ApotekSamariten operates a chain of drug store. The firm offers pain relief for joint and muscle problems. It also provides medicine for those who have problems with memory, ears, feet, balance, and for those with diabetes and cardiovascular diseases. The company is headquartered in Uppsala, Sweden. | Retail Trade |
| Kibacq AB | |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Health Technology |
| Kol Arts & Craft Handelsbolag | |
| Rjc Roger Johansson Consulting AB | |
| Virdings Alle Invest AB | |
| Forslid & Co. AB |
